Hiroshi Ida
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Hepatology 43
- Hepatocellular Carcinoma Treatment and Prognosis 29
- Hepatitis C virus research 7
- Liver Disease and Transplantation 5
- Oncology 12
- Cancer Immunotherapy and Biomarkers 7
- Co-authors
- Naoshi Nishida (56 shared papers)Masatoshi Kudo (53 shared papers)Satoru Hagiwara (53 shared papers)Yoshiaki Ito (11 shared papers)Kazuomi Ueshima (47 shared papers)Masahiro Takita (44 shared papers)Yasunori Minami (44 shared papers)Toshiharu Sakurai (29 shared papers)
- Journals
- Digestive Diseases (17 papers)Liver Cancer (8 papers)Oncology (8 papers)Cancers (8 papers)Hepatology Research (4 papers)
- Partner nations
- JapanSingaporeUnited States
In The Last Decade
Hiroshi Ida
81 papers receiving 2.7k citations
Hiroshi Ida's Hit Papers
Peers
Comparison fields: 5 of 72
- Hepatology 1.1k
- Cancer Research 288
- Oncology 317
- Rheumatology 165
- Molecular Biology 635
Countries citing papers authored by Hiroshi Ida
This map shows the geographic impact of Hiroshi Ida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ida more than expected).
Fields of papers citing papers by Hiroshi Ida
This network shows the impact of papers produced by Hiroshi Ida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ida. The network helps show where Hiroshi Ida may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Ida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 262 | |
| 2 | 2005 | 204 | |
| 3 | 2006 | 143 | |
| 4 | 2015 | 136 | |
| 5 | 2019 | 120 | |
| 6 | 2007 | 118 | |
| 7 | 2005 | 117 | |
| 8 | Achievement of Complete Response and Drug-Free Status by Atezolizumab plus Bevacizumab Combined with or without Curative Conversion in Patients with Transarterial Chemoembolization-Unsuitable, Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Proof-Of-Concept Study Hit paper breakdown → | 2023 | 112 |
| 9 | 2004 | 77 | |
| 10 | 2010 | 76 | |
| 11 | 2021 | 75 | |
| 12 | 2007 | 71 | |
| 13 | 2017 | 65 | |
| 14 | 2016 | 54 | |
| 15 | 2021 | 54 | |
| 16 | 2017 | 48 | |
| 17 | 2007 | 46 | |
| 18 | 2020 | 46 | |
| 19 | Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients. | 2009 | 45 |
| 20 | Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. | 2006 | 38 |
About Hiroshi Ida
Hiroshi Ida is a scholar working on Hepatology, Oncology, Cancer Research, Molecular Biology and Epidemiology, having authored 84 papers that have together received 2.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Cancer Immunotherapy and Biomarkers (7 papers), Hepatitis C virus research (7 papers), Epigenetics and DNA Methylation (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Liver Disease and Transplantation (5 papers), Ultrasound Imaging and Elastography (4 papers) and IgG4-Related and Inflammatory Diseases (4 papers). The work is most often cited by research in Hepatology (1.1k citations), Cancer Research (288 citations), Oncology (317 citations), Rheumatology (165 citations) and Molecular Biology (635 citations). Hiroshi Ida has collaborated with scholars based in Japan, Singapore and United States. Frequent co-authors include Naoshi Nishida, Masatoshi Kudo, Satoru Hagiwara, Yoshiaki Ito, Kazuomi Ueshima, Masahiro Takita, Yasunori Minami, Toshiharu Sakurai, Hirokazu Chishina and Tomohiro Minami. Their work appears in journals such as Digestive Diseases, Liver Cancer, Oncology, Cancers and Hepatology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.